Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Models in cytostatic chemotherapy.

N Brock, B Schneider

    Cancer
    |September 15, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Scientific models, particularly system models, are crucial for understanding chemotherapy. Experimental models in animals are essential for evaluating drug efficacy and safety in cancer treatment, guiding clinical decisions.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Transesophageal echocardiography to assess embolic risk in patients with atrial fibrillation. ELAT Study Group. Embolism in Left Atrial Thrombi.

    Annals of internal medicine·1998
    Same author

    [Symptomatic local therapy of the uncomplicated common cold. Multicenter controlled study of the effectiveness of an antiseptic lozenge].

    Fortschritte der Medizin·1998
    Same author

    Pre-steady state of reaction of nucleoside diphosphate kinase with anti-HIV nucleotides.

    The Journal of biological chemistry·1998
    Same author

    Role of Mg2+ in nucleoside diphosphate kinase autophosphorylation.

    Archives of biochemistry and biophysics·1998
    Same author

    Subdural hygromas after bone marrow transplantation: results of a prospective study.

    Transplantation·1998
    Same author

    [Hydro-CT in detection and staging of pancreatic carcinoma].

    Der Radiologe·1998
    Same journal

    Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study.

    Cancer·2026
    Same journal

    Large-scale osteosarcoma sequencing reveals age-associated genomic architectures.

    Cancer·2026
    Same journal

    EZH2 inhibitor tazemetostat voluntarily withdrawn from market.

    Cancer·2026
    Same journal

    Nivolumab and chemotherapy combination approved for previously untreated Hodgkin lymphoma.

    Cancer·2026
    Same journal

    Most older patients with advanced cancer prioritize QOL over extending survival: A secondary analysis of the GAP70+ trial found that among adults aged 70 and older with advanced, noncurable cancer, nearly three-quarters prioritized maintaining QOL.

    Cancer·2026
    Same journal

    Real-world safety, prognostic, and design considerations in ketogenic diet trials for pancreatic cancer.

    Cancer·2026
    See all related articles

    Area of Science:

    • * Chemotherapy research and drug development.
    • * Application of systems biology and mathematical modeling in pharmacology.
    • * Preclinical research methodologies in oncology.

    Background:

    • * Scientific theories function as intellectual system models, representing interrelations between scientific elements.
    • * Chemotherapy involves drug kinetics, receptor interactions, and effect-formation, all conceptualized as system models.
    • * Evaluating these models necessitates appropriate experimental models, especially in cancer chemotherapy.

    Purpose of the Study:

    • * To discuss fundamental system models in cancer chemotherapy.
    • * To highlight the role of experimental models in evaluating chemotherapy models and informing clinical practice.
    • * To emphasize the necessity of appropriate experimental models for different phases of preclinical drug development.

    Related Experiment Videos

    Main Methods:

    • * Utilizing living tumor-bearing animal models for evaluating scientific theories and making clinical inferences.
    • * Employing Bayes' theorem to assess probabilities and uncertainty in inductive inferences.
    • * Applying specific experimental models for drug screening, pharmacologic characterization, and preclinical pharmacology.

    Main Results:

    • * Experimental models are vital for screening, characterizing drug safety margins, and understanding time-effect and organotoxic effects.
    • * Test systems with chemosensitive tumors in rodents demonstrated efficiency in primary screening, achieving total cures with cyclophosphamide.
    • * Models provide insights into pharmacokinetics, pharmacodynamics, and potential drug interactions crucial for preclinical pharmacology.

    Conclusions:

    • * Appropriate experimental models are indispensable for the successful development and clinical application of anticancer drugs.
    • * The selection of experimental models must align with the specific clinical situation and the phase of drug development.
    • * System models and experimental validation are key to advancing cancer chemotherapy and improving patient outcomes.